Status:

COMPLETED

Preeclampsia Ratio (sFlt-1/PlGF)

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Collaborating Sponsors:

Institut National de la Santé Et de la Recherche Médicale, France

URC-CIC Paris Descartes Necker Cochin

Conditions:

Preeclampsia

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

The aim of the PRECOG study is to determine in a prospective interventional randomized study whether the implementation of a predictive test based on the sFLT-1/PlGF ratio improves perinatal care and ...

Detailed Description

Preeclampsia is a hypertensive disorder of pregnancy associated with placental insufficiency and is one of the major important of prematurity and maternal mortality worldwide. It complicates 2 to 7% o...

Eligibility Criteria

Inclusion

  • Patient hospitalized for suspected preeclampsia between 24WG+ 0 days and 35WG + 6 days,
  • Patiente with at least one of the following criteria:
  • Arterial hypertension defined by systolic BP ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg
  • Proteinuria greater than 0.3g / 24h or 0.3g / l or ≥ 3+
  • Proteinuria / creatinine ratio ≥ 30 mg / mmol
  • Pain in the epigastric bar
  • Generalized edema
  • Hepatic cytolysis\> 1.5N
  • Thrombocytopenia \<150000 / mm3 Informed consent signed by both parties Non-opposition was accepted by parental authority Age ≥ 18 years

Exclusion

  • Diagnosis of preeclampsia (arterial pressure\> 140/90 and proteinuria\> 0.3g / 24h or urine test\> 3+) or complete HELLP syndrome (Platelets \<100000 / mm3 and SGOT\> 2N and LDH and collapsed Haptoglobin)
  • IUGR with absent or reverse diastolic umbilical flow
  • Fetal heart rate abnormalities
  • Gestational age \<24 WG and\> 35 WG
  • Multiple pregnancy
  • Patient without health insurance
  • Non-consent of patient
  • Minor patient
  • Congenital malformation

Key Trial Info

Start Date :

April 26 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 27 2020

Estimated Enrollment :

84 Patients enrolled

Trial Details

Trial ID

NCT03289611

Start Date

April 26 2018

End Date

August 27 2020

Last Update

November 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU Cochin, Maternité Port Royal

Paris, France, 75014

Preeclampsia Ratio (sFlt-1/PlGF) | DecenTrialz